期刊文献+

组织芯片技术的建立及其在大肠癌的研究 被引量:27

Tissue microarray technology and its preliminary application in large intestinal Carcinoma
下载PDF
导出
摘要 目的:探讨石蜡包埋组织芯片技术的方法学及其在大肠癌研究中的意义.方法:选取病理科档案材料中44例大肠癌、13例癌旁结肠黏膜和26份大鼠结肠石蜡包埋组织,采用组织芯片仪及手工法制作208点列阵组织芯片,并进行he染色和mib-1抗体免疫组织化学染色.光镜观察并计数mib-1阳性细胞在各组的分布.结果:经染色后组织芯片大部结构完整,每一点阵均有代表性组织形态;mib-1阳性细胞标记指数(li)在中低分化大肠腺癌(50.17%)中明显高于高分化(管状)大肠腺癌(32.38%),而癌旁大肠黏膜li为10.08%.三者之间均具有非常显著性差异(p<0.01).结论:手工法组织芯片制作技术是一种简易可行的方法,在肿瘤病理研究中必将起到重要作用.mib-1阳性细胞标记指数与肿瘤细胞生长活跃程度相关,可作为判断大肠癌生物学行为及其预后的指标之一. AIM:To explore the methodology of tissue microarray (TMA) tec hnology and its application in tumor pathology. METHODS:Beecher tissue arrayer was used to create a 208-dot tis sue microarray, derived from 44 cases of large intestinal adenocarcinoma, 13 par a-cancerous colon tissues and 26 rat intestinal tissues which were formalin-fi xed and paraffin-embedded. Hematoxylin-eosin and immunohistochemical stains we re performed to evaluate the morphology and ki-67 expression in the specimens. The labeling index (LI) was calculated in the different groups of the tissues. RESULTS:Histologic appearance was well preserved in the most dot s of the TMA section. Labeling index of ki-67 in low-differentiated adenocarc inomas (50.17%) was much higher than that in well- differentiated ones (32.38%) and para-cancerous colon mucosa (10.08%). There were significant differences be tween them (P<0.01). CONCLUSION:Manual TMA technique is a simple and easy-doing meth od,which can be widely used in tumor pathology, expression profiling analysis an d genetic investigation of large-scale specimens.Ki-67 labeling index is well correlated with malignant behaviors and can be used to evaluate the patients' p rognosis.
出处 《世界华人消化杂志》 CAS 2002年第2期157-160,共4页 World Chinese Journal of Digestology
基金 全军十五科研基金课题 No.01MA071~~
  • 引文网络
  • 相关文献

参考文献47

  • 1Kallioniemi OP, Wagner U, Kononen J, Sauter G. Tissue microarray technology for high-throughput molecular profiling of cancer. Hum Mol Genetics 2001; 10:657-662
  • 2Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P,Leighton S, Torhors J, Mihatsch MJ, Sauter G, Kalioniemi OP.Tissue microarray for high-throughput molecular profiling of tumor specimens. Nature Med 1998; 4:844-847
  • 3Moch H, Kononen T, Kallioniemi OP, Sauter G. Tissue microarray: what will they bring to molecular and anatomic pathology? Adv Anat Pathol 2001 ;8:14-20
  • 4Rimm DL, Camp RL, Charette LA, Costa J, Olsen DA, Reiss M.Tissue microarray: a new technology for amplification of tissue resources. CancerJ 2001 ;7:24-31
  • 5Nagle RB. New molecular approaches to tissue analysis. J Histochem Cytochem 2001 ;49:1063-1064
  • 6Bubendorf L, Nocito A, Moch H, Sauter G. Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies. J Pathol 2001; 195: 72-79
  • 7Yang GP, Ross DT, Kuang WW, Brown PO, Weigel RJ. Combining SSH and cDNA microarrays for rapid identification of differentially expressed genes. Nucleic Acids Res 1999 ;27:1517-1523
  • 8Wang K, Gan L, Jeffery E, Gayle M, Gown AM, Skelly M, Nelson PS, Ng WV, Schummer M, Hood L, Mulligan J. Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray. Gene 1999;229:101-108
  • 9Khan J, Saal LH, Bittner ML, Chen Y, Trent JM, Meltzer PS.Expression profiling in cancer using eDNA microarrays. Electrophoresis1999; 20: 223-229
  • 10Khan J, Simon R, Bittner N, Chen Y, Leighton SB, Pohida T, Smith PD, Jiang Y, Gooden GC, Trent JM, Meltzer PS. Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays.Cancer Res 1998 ;58:5009-5013

同被引文献197

引证文献27

二级引证文献99

;
使用帮助 返回顶部